Clarithromycin in Multiple Myeloma Induction Therapy
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study evaluates the potential synergic anti-myeloma activity of clarithromycin when
combined with VCD induction therapy in patients with newly diagnosed multiple myeloma.